$HNST
Honest Company, Inc. Stock $hnst

$hnst Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000153097923000143 Filed on November 08, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$90.26M	$86.17M
YoY Change	10.27%	1.88%
Cost Of Revenue	$60.04M	$58.96M
YoY Change	1.15%	0.0%
Gross Profit	$30.23M	$27.21M
YoY Change	34.31%	6.2%
Gross Profit Margin	33.49%	31.57%
Selling, General & Admin	$27.42M	$24.15M
YoY Change	-19.13%	2.79%
% of Gross Profit	90.71%	88.76%
Research & Development	$1.577M	$1.584M
YoY Change	16.56%	-8.17%
% of Gross Profit	5.22%	5.82%
Depreciation & Amortization	$719.0K	$680.0K
YoY Change	-1.24%	6.42%
% of Gross Profit	2.38%	2.5%
Operating Expenses	$29.00M	$35.20M
YoY Change	-17.76%	-5.78%
Operating Profit	$1.230M	-$7.992M
YoY Change	-109.64%	-31.92%
Interest Expense	$15.00K	-$70.00K
YoY Change	-92.99%	141.38%
% of Operating Profit	1.22%
Other Income/Expense, Net		-$71.00K
YoY Change		144.83%
Pretax Income	$1.144M	-$8.063M
YoY Change	-109.12%	-31.48%
Income Tax	$0.00	$35.00K
% Of Pretax Income	0.0%
Net Earnings	$1.144M	-$8.098M
YoY Change	-109.09%	-31.3%
Net Earnings / Revenue	1.27%	-9.4%
Basic Earnings Per Share		-$0.09
Diluted Earnings Per Share	$0.01	-$0.09
COMMON SHARES
Basic Shares Outstanding	95.47M shares	94.98M shares
Diluted Shares Outstanding		95.18M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$32.83M	$23.10M
YoY Change	116.44%	-43.43%
Cash & Equivalents	$32.83M	$23.10M
Short-Term Investments	$0.00	$0.00
Other Short-Term Assets	$8.371M	$8.800M
YoY Change	-47.62%	-39.04%
Inventory	$73.49M	$79.51M
Prepaid Expenses
Receivables	$43.08M	$38.20M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$157.8M	$149.6M
YoY Change	-16.59%	-23.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$37.17M	$39.10M
YoY Change	-16.05%	-15.69%
Goodwill	$2.230M	$2.230M
YoY Change	0.0%	0.0%
Intangibles	$309.0K	$327.0K
YoY Change	-16.49%	-15.5%
Long-Term Investments
YoY Change
Other Assets	$4.141M	$4.249M
YoY Change	-9.55%	-14.18%
Total Long-Term Assets	$43.85M	$45.96M
YoY Change	-14.78%	-14.81%
TOTAL ASSETS
Total Short-Term Assets	$157.8M	$149.6M
Total Long-Term Assets	$43.85M	$45.96M
Total Assets	$201.6M	$195.5M
YoY Change	-16.2%	-21.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$22.29M	$18.49M
YoY Change	-9.96%	-39.77%
Accrued Expenses	$32.21M	$31.16M
YoY Change	-15.26%	3.99%
Deferred Revenue	$2.212M	$1.861M
YoY Change	171.41%	138.28%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$23.00K	$0.00
YoY Change	-55.77%	-100.0%
Total Short-Term Liabilities	$56.71M	$51.52M
YoY Change	-10.81%	-16.17%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$34.00K	$222.0K
YoY Change	-95.84%	572.73%
Total Long-Term Liabilities	$34.00K	$222.0K
YoY Change	-95.84%	572.73%
TOTAL LIABILITIES
Total Short-Term Liabilities	$56.71M	$51.52M
Total Long-Term Liabilities	$34.00K	$222.0K
Total Liabilities	$78.48M	$75.53M
YoY Change	-16.72%	-19.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$479.1M	-$480.2M
YoY Change	8.92%	12.4%
Common Stock	$9.000K	$9.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$123.1M	$120.0M
YoY Change
Total Liabilities & Shareholders Equity	$201.6M	$195.5M
YoY Change	-16.2%	-21.27%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	$1.144M	-$8.098M
YoY Change	-109.09%	-31.3%
Depreciation, Depletion And Amortization	$719.0K	$680.0K
YoY Change	-1.24%	6.42%
Cash From Operating Activities	$9.922M	$5.670M
YoY Change	-138.75%	-122.44%
INVESTING ACTIVITIES
Capital Expenditures	$260.0K	$400.0K
YoY Change	41.3%	-157.97%
Acquisitions
YoY Change
Other Investing Activities	$3.000K	$0.00
YoY Change	-99.97%	-100.0%
Cash From Investing Activities	-$260.0K	-$400.0K
YoY Change	-102.37%	-104.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	62.00K	-10.00K
YoY Change	-19.48%	-87.18%
NET CHANGE
Cash From Operating Activities	9.922M	5.670M
Cash From Investing Activities	-260.0K	-400.0K
Cash From Financing Activities	62.00K	-10.00K
Net Change In Cash	9.724M	5.260M
YoY Change	-166.74%	-132.35%
FREE CASH FLOW
Cash From Operating Activities	$9.922M	$5.670M
Capital Expenditures	$260.0K	$400.0K
Free Cash Flow	$9.662M	$5.270M
YoY Change	-137.46%	-121.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1584000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	0	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	5650000	usd
CY2023Q3	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	38203000	usd
CY2022Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	42334000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	79507000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	115664000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8770000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15982000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	189147000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25266000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29947000	usd
CY2023Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	13883000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	14327000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	2230000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	2230000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	327000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	370000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4578000	usd
CY2023Q3	us-gaap	Assets Assets	195538000	usd
CY2022Q4	us-gaap	Assets Assets	240599000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	18491000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	24755000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	31164000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38010000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1861000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	815000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	51516000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	63580000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23791000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	29842000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	222000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	817000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	75529000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	94239000	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	9000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	9000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	600211000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	586213000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-480211000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-439830000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	120009000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	146360000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	195538000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	84580000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	254101000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	231792000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	58964000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	58963000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	183796000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	161984000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	27205000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	25617000	usd
	us-gaap	Gross Profit GrossProfit	70305000	usd
	us-gaap	Gross Profit GrossProfit	69808000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24146000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	23491000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	74995000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	63068000	usd
CY2023Q3	us-gaap	Marketing Expense MarketingExpense	9110000	usd
CY2022Q3	us-gaap	Marketing Expense MarketingExpense	12140000	usd
	us-gaap	Marketing Expense MarketingExpense	28605000	usd
	us-gaap	Marketing Expense MarketingExpense	38121000	usd
CY2023Q3	us-gaap	Restructuring Charges RestructuringCharges	357000	usd
CY2022Q3	us-gaap	Restructuring Charges RestructuringCharges	0	usd
	us-gaap	Restructuring Charges RestructuringCharges	2104000	usd
	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1725000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4638000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	35197000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	37356000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-7992000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	657000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40306000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-36367000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	75000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	60000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-8098000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-11788000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-40381000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-36427000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	94137244	shares
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	33000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-42000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8098000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11751000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-40348000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36469000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	179106000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-14626000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-77000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	113000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3548000	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	20000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	168889000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-10012000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	9000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3912000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	157000	usd
CY2022Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	17000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-18867000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2021	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201602Member
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q3	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q3	us-gaap	Assets Current AssetsCurrent	149583000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4249000	usd
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	92907351	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	92907351	shares
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-32000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	240599000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	86169000	usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95179604	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	94137244	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	92020423	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92020423	shares
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	37000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	162936000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-11788000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	37000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3900000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	155085000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	146360000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	19000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3772000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	131284000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-13416000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	13000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6413000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	102000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	124400000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-8098000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3707000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	120009000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-40381000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-36427000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2021000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2025000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	13892000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	11360000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	4680000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	4805000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4132000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7087000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-36158000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	24609000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7498000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3228000	usd
	hnst	Increase Decrease In Accounts Payable Accrued Liabilities And Other Long Term Liabilities IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOtherLongTermLiabilities	-13875000	usd
	hnst	Increase Decrease In Accounts Payable Accrued Liabilities And Other Long Term Liabilities IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOtherLongTermLiabilities	7604000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1046000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	49000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5740000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5161000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9431000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-50669000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	12782000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	5683000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	38219000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1588000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1433000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4095000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	24004000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	122000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	157000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	281000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	13586000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9517000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	50791000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	25000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	92000	usd
	us-gaap	Nature Of Operations NatureOfOperations	Nature of BusinessThe Honest Company, Inc. (the “Company”) was incorporated in the State of California on July 19, 2011 and on May 23, 2012 was re-incorporated in the State of Delaware under the same name. The Company is a digitally-native consumer products company dedicated to creating clean- and sustainably-designed products spanning baby care, beauty, personal care, wellness and household care. The Company sells its products through digital and retail sales channels in the following product categories: Diapers and Wipes, Skin and Personal Care, and Household and Wellness.
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and contingent liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s estimates, which are subject to varying degrees of judgment, include the valuation of inventories, sales returns and allowances, allowances for credit losses, valuation of short-term investments, capitalized software, useful lives associated with long-lived assets, incremental borrowing rates associated with leases, valuation allowances with respect to deferred tax assets, accruals and contingencies, recoverability of non-cash marketing credits, recoverability of goodwill and long-lived assets, and the valuation and assumptions underlying stock-based compensation. On an ongoing basis, the Company evaluates its estimates compared to historical experience and trends, which form the basis for making judgments about the carrying value of assets and liabilities.</span></div>The Company assessed certain accounting matters and estimates that generally require consideration of forecasted information in context with the information reasonably available to the Company as of September 30, 2023 and through the date these condensed consolidated financial statements were issued. Management is not aware of any specific event or circumstance that would require an update to estimates or judgments or a revision to the carrying value of assets or liabilities. However, these estimates and judgments may change as new events occur and additional information is obtained, which may result in changes being recognized in the Company’s consolidated financial statements in future periods. For example, based on macro trends within our Household and Wellness product category, consumer demand for sanitizing and disinfecting products decreased over the past few years. As a result, the Company made a decision to exit certain elements of these products during the quarter ended March 31, 2023. Refer to Note 14, "Restructuring" included in these condensed consolidated financial statements for more information on the Company's restructuring initiatives.
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	900000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	500000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	86169000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	84580000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	254101000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	231792000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	86169000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	84580000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	254101000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	231792000	usd
CY2023Q3	hnst	Accrued Inventory Purchases AccruedInventoryPurchases	7545000	usd
CY2022Q4	hnst	Accrued Inventory Purchases AccruedInventoryPurchases	17050000	usd
CY2023Q3	hnst	Accrued Return Liabilities AccruedReturnLiabilities	273000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	5700000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	0	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	5682000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	33000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	5650000	usd
CY2023Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	6245000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	6790000	usd
CY2022Q4	hnst	Accrued Return Liabilities AccruedReturnLiabilities	318000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7999000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7688000	usd
CY2023Q3	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	384000	usd
CY2022Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	0	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8718000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6164000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	31164000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38010000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14888007	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.24
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2300	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.70
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1550149	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.16
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13335558	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.25
CY2021Q2	hnst	Share Based Compensation Arrangement By Share Based Payment Award Purchase Period ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod	P6M
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3707000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3900000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13892000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11360000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-8098000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-11788000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-40381000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-36427000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8098000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8098000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11788000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11788000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-40381000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-40381000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-36427000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-36427000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95179604	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92460987	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	94137244	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92020423	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95179604	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	92460987	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	94137244	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	92020423	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20798971	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19919596	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20798971	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19919596	shares
	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	usd
	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	usd
CY2023Q3	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	usd
	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
CY2023Q3	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
CY2022Q3	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	12000	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	62000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	42000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	241000	usd
CY2023Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
CY2022Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	7000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1792000	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1795000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	5376000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	5362000	usd
CY2023Q3	us-gaap	Sublease Income SubleaseIncome	501000	usd
CY2022Q3	us-gaap	Sublease Income SubleaseIncome	501000	usd
	us-gaap	Sublease Income SubleaseIncome	1503000	usd
	us-gaap	Sublease Income SubleaseIncome	1504000	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	1303000	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	1357000	usd
	us-gaap	Lease Cost LeaseCost	3915000	usd
	us-gaap	Lease Cost LeaseCost	4106000	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	28000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25266000	usd
CY2023Q3	hnst	Lease Right Of Use Asset LeaseRightOfUseAsset	25294000	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	32000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7999000	usd
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23791000	usd
CY2023Q3	hnst	Lease Liability LeaseLiability	31825000	usd
CY2023Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y10M24D
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M18D
CY2023Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0300
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0229
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	1000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	5740000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	46000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd

Files In Submission

Name	View Source	Status
0001530979-23-000143-index-headers.html	Edgar Link	pending
0001530979-23-000143-index.html	Edgar Link	pending
0001530979-23-000143.txt	Edgar Link	pending
0001530979-23-000143-xbrl.zip	Edgar Link	pending
hnst-20230930_cal.xml	Edgar Link	unprocessable
hnst-20230930_lab.xml	Edgar Link	unprocessable
exhibit101-dlorettaexecuti.htm	Edgar Link	pending
exhibit102-kkennedyseparat.htm	Edgar Link	pending
exhibit104-honestcoxlsaam2.htm	Edgar Link	pending
exhibits103-honestcoxlsaam.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hnst-20230930.htm	Edgar Link	pending
hnst-20230930.xsd	Edgar Link	pending
hnst-20230930_g1.jpg	Edgar Link	pending
honestcoq3-23exhibit311.htm	Edgar Link	pending
honestcoq3-23exhibit312.htm	Edgar Link	pending
honestcoq3-23exhibit321.htm	Edgar Link	pending
honestcoq3-23exhibit322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hnst-20230930_def.xml	Edgar Link	unprocessable
hnst-20230930_pre.xml	Edgar Link	unprocessable
hnst-20230930_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HNST
Honest Company, Inc. Stock $hnst

2023 Q4 Form 10-Q Financial Statement

#000153097923000143 Filed on November 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HNST Honest Company, Inc. Stock $hnst

2023 Q4 Form 10-Q Financial Statement

#000153097923000143 Filed on November 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HNST
Honest Company, Inc. Stock $hnst